METHOD AND APPARATUS FOR INFLUENCING AN AUTOMATIC TRANSMISSION
    1.
    发明申请
    METHOD AND APPARATUS FOR INFLUENCING AN AUTOMATIC TRANSMISSION 有权
    影响自动传输的方法和装置

    公开(公告)号:US20140011636A1

    公开(公告)日:2014-01-09

    申请号:US14006619

    申请日:2012-02-01

    IPC分类号: B60W10/11 B60W10/06

    摘要: An apparatus for influencing an automatic transmission has a man-machine-interface, which is connected to a transmission controller for selecting a transmission ratio of the automatic transmission connected to an internal combustion engine, and a monitoring device for monitoring at least one operating parameter that is relevant to the wear of the internal combustion engine, wherein a threshold value of the operating parameter and a desired rotation speed range of the internal combustion engine that depends on the threshold value can be selected via the man-machine-interface, and wherein the transmission controller selects a transmission ratio on the basis of the monitoring device, by which an actual rotation speed of the internal combustion engine is adjusted within the desired rotation speed range. A method for influencing an automatic transmission is also described.

    摘要翻译: 一种用于影响自动变速器的装置具有人机界面,其连接到用于选择连接到内燃机的自动变速器的变速比的变速器控制器和用于监视至少一个操作参数的监控装置, 与内燃机的磨损有关,其中可以经由人机界面选择依赖于阈值的内燃机的运行参数和期望转速范围的阈值,并且其中, 变速器控制器根据监视装置选择传动比,通过该监视装置将内燃机的实际转速调节到期望的转速范围内。 还描述了影响自动变速器的方法。

    Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action

    公开(公告)号:US06432987B1

    公开(公告)日:2002-08-13

    申请号:US09736431

    申请日:2000-12-15

    IPC分类号: A01N4340

    摘要: The invention relates to novel, substituted N-benzyl-indol-3-ylglyoxylic acid derivatives of the following formula and their use for the treatment of oncoses The invention further relates to their physiologically tolerable acid addition salts and if possible their N-oxides. In addition, the invention relates to pharmaceutical preparations containing at least one of the compounds of the abovementioned formula or their salts or N-oxides with physiologically tolerable inorganic or organic acids and, if appropriate, pharmaceutically utilizable vehicles and/or diluents or excipients and also administration forms of the compounds of the abovementioned formula containing at least one of the compounds of this formula or their salts in the form of tablets, coated tablets, capsules, solutions for infusion or ampoules, suppositories, patches, powder preparations which can be employed by inhalation, suspensions, creams and ointments

    IN-PROCESS CONTROL IN A METHOD FOR PRODUCING EPO
    7.
    发明申请
    IN-PROCESS CONTROL IN A METHOD FOR PRODUCING EPO 审中-公开
    生产EPO的方法中的过程控制

    公开(公告)号:US20120021441A1

    公开(公告)日:2012-01-26

    申请号:US13140190

    申请日:2009-12-07

    IPC分类号: G01N33/74 G01N21/78

    CPC分类号: G01N33/746

    摘要: The invention relates to a method for determining the isoform composition of erythropoietin, comprising the following steps: a) isoelectrical focusing of a sample comprising erythropoietin in a gel over a pH range having a lower limit of 2.5 to 3.5 and an upper limit of 5 to 8, wherein the sample comprising erythropoietin originates from a culture supernatant of erythropoietin producing eukaryotic cells; b) transferring of the proteins comprised and separated in the gel to a membrane; c) verifying the erythropoietin bound to the membrane by specific antibodies; and to a method for in-process control of culture supernatants of erythropoietin producing eukaryotic cells during the fermentative production process.

    摘要翻译: 本发明涉及一种测定红细胞生成素的同种型组成的方法,包括以下步骤:a)将包含促红细胞生成素的样品在凝胶中的等电聚焦在pH范围内,其下限为2.5至3.5,上限为5至 8,其中包含促红细胞生成素的样品源自产生促红细胞生成素的真核细胞的培养上清液; b)将在凝胶中包含和分离的蛋白质转移到膜上; c)通过特异性抗体验证与该膜结合的促红细胞生成素; 以及在发酵生产过程中用于在产生促红细胞生成素的真核细胞的培养物上清液中进行过程控制的方法。